Summary
Recently, we demonstrated insulin resistance due to reduced glucose storage in young relatives of Type 2 diabetic patients. To investigate whether this was associated with a defective insulin receptor kinase, we studied ten of these young (27±1 years old) non-obese glucose tolerant first degree relatives of patients with Type 2 diabetes and eight matched control subjects with no family history of diabetes. Insulin sensitivity was assessed by a hyperinsulinaemic, euglycaemic clamp. Insulin receptors were partially purified from muscle biopsies obtained in the basal and the insulin-stimulated state during the clamp. Insulin binding capacity was decreased by 28% in the relatives (p<0.05) in the basal biopsy. Tyrosine kinase activity in the receptor preparation was decreased by 50% in both basal and insulin-stimulated biopsies from the relatives. After stimulation with insulin “in vitro”, kinase activity was reduced in the relatives in basal (p<0.005) and insulin-stimulated (p<0.01) biopsies and also when expressed per insulin binding capacity (p≈0.05). Insulin stimulation of non-oxidative glucose metabolism correlated with “in vitro” insulin-stimulated tyrosine kinase activity (r=0.61, p<0.01) and also when expressed per binding capacity (r=0.53, p<0.025). We suggest that the marked defect in tyrosine kinase activity in partially purified insulin receptors from skeletal muscle is an early event in the development of insulin resistance and contributes to the pathophysiology of Type 2 diabetes.
Article PDF
Similar content being viewed by others
References
DeFronzo RA (1988) The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37: 667–687
Olefsky JM, Ciaraldi TP, Kolterman OG (1985) Mechanism of insulin resistance in non-insulin-dependent (type II) diabetes. Am J Med 79: 12–22
Kolterman OG, Gray RS, Bernstein J, Insel J, Scarlett JA, Olefsky JM (1981) Receptor and post receptor defects contribute to the insulin resistance in non-insulin-dependent diabetes mellitus. J Clin Invest 68: 957–969
Reaven GM, Chen YI, Coulston AM et al. (1983) Insulin secretion and action in non-insulin-dependent diabetes mellitus. Am J Med 75: 23–31
Porte D Jr (1991) Beta-cells in type II diabetes mellitus. Diabetes 40: 166–180
Eriksson J, Franssila-Kallunki A, Ekstrand A et al. (1989) Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321: 337–343
Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR (1990) Slow glucose removal rate and hyperinsulinemia precede the development of Type 2 diabetes in offspring of diabetic patients. Ann Intern Med 113: 909–915
Lillioja S, Mott DM, Howard BV et al. (1988) Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318: 1217–1225
Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK (1988) Increased insulin concentrations in nondiabetic offspring of diabetic parents. N Engl J Med 319: 1297–1301
Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH (1988) The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319: 1500–1506
Newman B, Selby JV, King M-C, Slemenda C, Fabsitz R, Friedman GD (1987) Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 30: 763–768
Knowler WC, Pettitt DJ, Saad MF, Bennett PH (1990) Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diab Metab Rev 6: 1–27
Barnett AH, Spiliopoulos AJ, Pyke DA, Stubbs WA, Burrin J, Alberti KGMM (1981) Metabolic studies in unaffected co-twins of non-insulin dependent diabetics. BMJ 282: 1656–1658
Vaag A, Henriksen JE, Beck-Nielsen H (1992) Decreased insulin activation of glycogen synthase in skeletal muscle in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89: 782–788
Arner P, Pollare T, Lithell H, Livingston JN (1987) Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 437–440
Caro JF, Sinha MK, Raju SM et al. (1987) Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest 79: 1330–1337
Obermaier-Kusser B, White MF, Pongratz DE et al. (1989) Adefective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus. J Biol Chem 264: 9497–9504
Maegawa H, Shigeta Y, Egawa K, Kobayashi M (1991) Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM. Diabetes 40: 815–819
Nyomba BL, Ossowski VM, Bogardus C, Mott DM (1990) Insulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans. Am J Physiol 258:E964-E974
Brillon DJ, Freidenberg GR, Henry RR, Olefsky JM (1989) Mechanism of defective insulin-receptor kinase activity in NIDDM. Evidence of two receptor populations. Diabetes 38: 397–403
Freidenberg GR, Reichart D, Olefsky JM, Henry RR (1988) Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. J Clin Invest 82: 1398–1406
Bak JF, Smitz O, Sorensen NS, Pedersen O (1989) Postreceptor effects of sulfonylurea on skeletal muscle glycogen synthase activity in type II diabetic patients. Diabetes 38: 1343–1350
Scott Thies R, Molina JM, Ciaraldi TP, Freidenberg GF, Olefsky JM (1990) Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects. Diabetes 39: 250–259
Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA (1991) The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 72: 96–107
McGuire MC, Fields RM, Nyomba BL et al. (1991) Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans. Diabetes 40: 939–942
Damsbo P, Vaag A, Hother-Nielsen O, Beck-Nielsen H (1991) Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34: 239–245
Haring HU (1991) The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistance. Diabetologia 34: 848–861
Schulman D, Rothman DL, Jue T, Stein P, DeFronzo RA, Schulman GR (1990) Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin dependent diabetes by 13C-nuclear magnetic resonance spectroscopy. N Engl J Med 322: 223–228
Handberg A, Vaag A, Damsbo P, Beck-Nielsen H, Vinten J (1990) Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia 33: 625–627
Pedersen O, Bak JF, Andersen PH et al. (1990) Evidence against altered expression of GLUT 1 or GLUT 4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39: 865–870
Eriksson J, Koranyi L, Bourey R et al. (1992) Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT 4) gene in human skeletal muscle. Diabetologia 35: 143–147
Dohm GL, Elton CW, Friedman JE et al. (1991) Decreased expression of glucose transporters in muscle from insulin-resistant patients. Am J Physiol 260:E459-E463
Dent P, Lavoinne A, Nakeilny S, Caudwell FB, Watt P, Cohen P (1990) The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle. Nature 348: 302–308
Steele R (1959) Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82: 420–430
Bryer-Ash M (1989) Rat insulin-receptor kinase activity correlates with in vivo insulin action. Diabetes 38: 108–116
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle protein-dye bonding. Anal Biochem 72: 248–254
Ganderton RH, Stanley KK, Field CE, Coghlan MP, Soos MA, Siddle K (1992) A monoclonal anti-peptide antibody reacting with the insulin receptor β-subunit. Biochem J 228: 195–205
Taylor R, Soos MA, Wells A, Argyraki M, Siddle K (1987) Insulin-like and insulin-inhibitory effects of monoclonal antibodies for different epitopes on the human insulin receptor. Biochem J 242: 123–129
Christiansen K, Tranum-Jensen J, Carlsen J, Vinten J (1991) A model for the quarternary structure of human placental insulin receptor deduced from electron microscopy. Proc Natl Acad Sci USA 88: 249–252
Freidenberg GR, Suter SL, Henry RR, Reichart D, Olefsky JM (1991) In vivo stimulation of the insulin receptor kinase in human skeletal muscle. Correlation with insulin-stimulated glucose disposal during euglycemic clamp studies. J Clin Invest 87: 2222–2229
Moeller DE, Yokota A, Flier JS (1989) Normal insulin receptor cDNA sequence in Pima Indians with NIDDM. Diabetes 38: 1496–1500
Kusari J, Verma US, Buse JB, Henry RR, Olefsky JM (1989) Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT 4) in patients with common-type non-insulin-dependent diabetes mellitus. J Clin Invest 88: 1323–1330
Cama A, Patterson AP, Kadowaki T et al. (1990) The amino acid sequence of the insulin receptor is normal in an insulin-resistant Pima Indian. J Clin Endocrinol Metab 70: 1155–1161
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Handberg, A., Vaag, A., Vinten, J. et al. Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first degree relatives of patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36, 668–674 (1993). https://doi.org/10.1007/BF00404079
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00404079